<DOC>
	<DOC>NCT00857675</DOC>
	<brief_summary>The purpose of this study is to determine whether Adefovir Dipivoxil is effective and safe in treatment of Chinese Patients with HBeAg positive Chronic Hepatitis B for 5 years.</brief_summary>
	<brief_title>A Efficacy and Safety Study of Adefovir Dipivoxil to Treat Chinese Patients With HBeAg+ve Chronic Hepatitis B</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis, Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B, Chronic</mesh_term>
	<mesh_term>Adefovir</mesh_term>
	<mesh_term>Adefovir dipivoxil</mesh_term>
	<criteria>Aged 1865 years Presence of HBsAg and HBeAg at the time of screening and for at least 6 months prior to screening. Positive HBV DNA plasma assay with screening value equal or more than 10 (6) copies/mL (Roche COBAS AMPLICORTM HBV MONITOR Test, LLOD less than 300 copies/mL) at the time of screening (within 4 weeks of randomisation). Evidence of elevated serum ALT levels defined as serum ALT level greater than or equal to 2.0 times (inclusive) the upper limit of the normal range (ULN) in the previous 6 months, and serum ALT levels greater than 1.0 times the ULN at the time of screening. Evidence of hepatocellular carcinoma; Clinical signs of liver decompensation; Serum creatinine more than 1.5 mg/dL; ALT more than 10 x ULN; seropositivity for hepatitis C or D virus or HIV; Lamivudine therapy within 3 months prior to screening; ADV therapy or any other antiHBV therapy within the previous 6 months; Use of systemic antiviral agents, immunomodulators, immunosuppressive therapy, Chinese Traditional Medicines or agents known to lower ALT levels during the study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>HBV DNA suppression</keyword>
	<keyword>ALT normalisation</keyword>
	<keyword>Viral resistance</keyword>
	<keyword>HBeAg seroconversion</keyword>
</DOC>